| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2024―Apr―09 |
Discovery of components in honeysuckle for treating COVID-19 and diabetes based on molecular docking, network analysis and experimental validation |
Feng Xu, Ya Qin, Changxiu Guan |
| 2 |
[GO] |
2024―Apr―02 |
Identification of potential antiviral compounds from Egyptian sea stars against MERS-CoV with the in vitro and in silico experiments |
Nadia I. Okasha, Mohamed A. Abdel-Rahman, Mohamed S. Nafie, Noura M. Abo Shama, Sara H. Mahmoud, Dalia A. El-Ebeedy, Ahmed Z. Abdel Azeiz |
| 3 |
[GO] |
2024―Apr―01 |
Isolation, characterization and SARS-CoV-2 3CL protease inhibitory activity of a new methylsulfinyl-butanyl derivative from Raphani Semen |
Huanjun Wang, Bingqing Chi, Caiyu Li, Zhenhua Tian, Yuecheng Liu |
| 4 |
[GO] |
2024―Mrz―22 |
Molecular docking and molecular dynamic simulation-based phytoconstituents against SARS-CoV-2 with dual inhibition of the primary protease targets |
Sachin A. Dhawale, Sadhana Mahajan, Madhuri Pandit, Sachin Gawale, Mangesh Ghodke, Ganesh Tapadiya |
| 5 |
[GO] |
2024―Feb―09 |
A review on the effective natural compounds of medicinal plants on the COVID-19 |
Saghar Ketebchi, Maryam Papari Moghadamfard |
| 6 |
[GO] |
2024―Jan―08 |
Evaluation of natural products from virtual screenings as SARS-CoV-2 main protease inhibitors using combinational experiments |
Jiahao Zhou, Rui Zhang, Haohao Yan, Xiaoping Liu, Chao Shang, Yunyu Chen |
| 7 |
[GO] |
2023―Nov―15 |
Structure-based virtual screening, ADMET analysis, and molecular dynamics simulation of Moroccan natural compounds as candidates for the SARS-CoV-2 inhibitors |
Oussama Abchir, Hassan Nour, Ossama Daoui, Imane Yamari, Souad ElKhattabi, Mhammed El Kouali, et al. (+3) Mohammed Talbi, Abdelkbir Errougui, Samir Chtita |
| 8 |
[GO] |
2023―Sep―21 |
Network pharmacology and molecular docking to scientifically validate the potential mechanism of Lonicerae japonicae flos in the clinical treatment of COVID-19 |
Yisheng Huang, Yan Fang, Huanhuan Jie, Hongbiao Yang, Wen Zhou, Yijian Chen, Baolin Zhong |
| 9 |
[GO] |
2023―Sep―10 |
Natural PAK1 inhibitors: potent anti-inflammatory effectors for prevention of pulmonary fibrosis in COVID-19 therapy |
Idris Arslan |
| 10 |
[GO] |
2023―Aug―17 |
Identification of potential antiviral compounds from Egyptian Red Sea soft corals against Middle East respiratory syndrome coronavirus |
Mariam M. Abdelfattah, Montaser A. El-Hammady, Ahmed Mostafa, Omnia Kutkat, Noura M. Abo Shama, Mohamed S. Nafie, et al. (+2) Dalia A. El-Ebeedy, Ahmed Z. Abdel Azeiz |
| 11 |
[GO] |
2023―Aug―03 |
Invalidation of geraniin as a potential inhibitor against SARS-CoV-2 main protease |
Rui Zhang, Haohao Yan, Jiahao Zhou, Xiaoping Liu, Yunyu Chen |
| 12 |
[GO] |
2023―Jul―12 |
Neutralizing activity of Usnic acid and β-cyclodextrins complex against SARS-CoV-2 spike pseudovirus |
Luigi Rosa, Antimo Cutone, Rebecca Galla, Francesca Uberti, Piera Valenti |
| 13 |
[GO] |
2023―Jul―05 |
The sesquiterpenes with the COVID-19 Mpro inhibitory activity from the Carpesium abrotanoides L. |
Yu-Wen Fan, Zhuo-Yi Ao, Wei-Jie Zhang, Jia-Yan Chen, Xin Lian, Yong- Chen Pan, et al. (+3) Li-Ping Chen, Jie-Wei Wu, Jie Yuan |
| 14 |
[GO] |
2023―Mrz―29 |
Antiviral activity of curcumin and its analogs selected by an artificial intelligence-supported activity prediction system in SARS-CoV-2-infected VeroE6 cells |
Koji Teshima, Takeshi Tanaka, Ye Zhengmao, Ken Ikeda, Takao Matsuzaki, Tamotsu Shiroma, et al. (+4) Ayumu Muroya, Masato Hosoda, Mayo Yasugi, Hirotsugu Komatsu |
| 15 |
[GO] |
2022―Okt―27 |
Efficient synthesis of novel colchicine-magnolol hybrids and evaluation of their inhibitory activity on key proteases of 2019-nCoV replication and acute lung injury |
Liu-Yang Pu, Zhiyue Li, Feijuan Huang, Limin Li, Yucui Ma, Min Ma, et al. (+2) Shengquan Hu, Zhengzhi Wu |
| 16 |
[GO] |
2022―Sep―19 |
Oxytocin in diabetic Covid-19 patients: a new perspective |
Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Omayma A. Eldahshan, Gaber El-Saber Batiha |
| 17 |
[GO] |
2022―Aug―17 |
Abietic, maleopimaric and quinopimaric dipeptide Ugi-4CR derivatives and their potency against influenza A and SARS-CoV-2 |
Elena V. Tretyakova, Xinyuan Ma, Oxana B. Kazakova, Anna A. Shtro, Galina D. Petukhova, Anna A. Smirnova, et al. (+2) Huan Xu, Sulong Xiao |
| 18 |
[GO] |
2022―Aug―15 |
Phenolic compounds of Zanthoxylum armatum DC as potential inhibitors of urease and SARS-CoV2 using molecular docking approach and with simulation study |
Nilamoni Chelleng, Minakshi Puzari, Pankaj Chetia, Chandan Tamuly |
| 19 |
[GO] |
2022―Jun―25 |
Screening of honey bee pollen constituents against COVID-19: an emerging hot spot in targeting SARS-CoV-2-ACE-2 interaction |
Armin Zarei, Ali Ramazani, Aram Rezaei, Sajad Moradi |
| 20 |
[GO] |
2022―Mrz―26 |
Exploring SARS-CoV-2 Delta variant spike protein receptor-binding domain (RBD) as a target for tanshinones and antimalarials |
Paolo Coghi, Xiao Yun Yun, Jerome P. L. Ng, Betty Yuan Kwan Law, Maurizio Memo, Alessandra Gianoncelli, et al. (+2) Vincent Kam Wai Wong, Giovanni Ribaudo |
| 21 |
[GO] |
2022―Feb―24 |
Geraniin as a potential inhibitor of SARS-CoV-2 3CLpro |
Wen-Di Yu, Qi-Ying Jin, Mao-Sen Zeng, Jin-Yuan Liu, Pei-Ping Xu |
| 22 |
[GO] |
2022―Feb―20 |
Isolation, structural elucidation and molecular docking studies against SARS-CoV-2 main protease of new stigmastane-type steroidal glucosides isolated from the whole plants of Vernonia gratiosa |
Pham Van Cong, Hoang Le Tuan Anh, Nguyen Quang Trung, Bui Quang Minh, Ngo Viet Duc, Nguyen Van Dan, et al. (+5) Nguyen Minh Trang, Nguyen Viet Phong, Le Ba Vinh, Le Tuan Anh, Ki Yong Lee |
| 23 |
[GO] |
2022―Jan―13 |
SARS-CoV-2 main protease and papain-like protease inhibition by abietane-type diterpenes isolated from the branches of Glyptostrobus pensilis using molecular docking studies |
Nguyen Viet Phong, Nguyen Minh Trang, Cao Thao Quyen, Hoang Le Tuan Anh, Le Ba Vinh |
| 24 |
[GO] |
2021―Dez―28 |
Phytochemical and in silico studies for potential constituents from Centaurium spicatum as candidates against the SARS-CoV-2 main protease and RNA-dependent RNA polymerase |
Ahmed E. Allam, Mohamed E. Abouelela, Hamdy K. Assaf, Ahmed M. Sayed, Alaa M. Nafady, Mohamed A. El-Shanawany, et al. (+2) Fumihide Takano, Tomihisa Ohta |
| 25 |
[GO] |
2021―Dez―15 |
Discovery of potent inhibitors for Mpro enzyme of SARS-COV2 by multi-stage in-silico screening of Alkannin/shikonin |
Nitish Kumar, Jatinder Vir Singh, Kavita Bhagat, Harmandeep Kaur Gulati, Anchal Sharma, Archana Rani, et al. (+5) Amit Duggal, Puja Gulati, Harbinder Singh, Preet Mohinder Singh Bedi, Sarabjit Kaur |
| 26 |
[GO] |
2021―Okt―25 |
Phytochemicals of Zingiberaceae family exhibit potentiality against SARS-CoV-2 main protease identified by a rational computer-aided drug design |
Sudhan Debnath, Samhita Bhaumik, Debanjan Sen, Bimal Debnath |
| 27 |
[GO] |
2021―Sep―28 |
Extraction and characterization of metabolites from Olea europaea pulp and their molecular docking against SARS-CoV-2 main-protease (Mpro) |
Venkataraghavan Ragunathan, K. Chithra |
| 28 |
[GO] |
2021―Sep―21 |
22-Hydroxyhopane, a novel multitargeted phytocompound against SARS-CoV-2 from Adiantum latifolium Lam |
R. Pradeep Kumar, Simna Siddique |
| 29 |
[GO] |
2021―Sep―09 |
In silico evaluation of COVID-19 main protease interactions with honeybee natural products for discovery of high potential antiviral compounds |
Armin Zarei, Ali Ramazani, Saeed Pourmand, Ahmad Sattari, Aram Rezaei, Sajad Moradi |
| 30 |
[GO] |
2021―Jun―10 |
Virtual screening, ADMET profiling, PASS prediction, and bioactivity studies of potential inhibitory roles of alkaloids, phytosterols, and flavonoids against COVID-19 main protease (Mpro) |
Misbaudeen Abdul-Hammed, Ibrahim Olaide Adedotun, Monsurat Olajide, Christianah Otoame Irabor, Tolulope Irapada Afolabi, Ibrahim Olajide Gbadebo, et al. (+2) Lydia Rhyman, Ponnadurai Ramasami |
| 31 |
[GO] |
2021―Mai―24 |
Natural metabolites from the soft coral Nephthea sp. as potential SARS-CoV-2 main protease inhibitors |
Omnia Hesham Abdelhafez, John Refaat Fahim, Muhamad Mustafa, Asmaa M. AboulMagd, Samar Yehia Desoukey, Alaa M. Hayallah, et al. (+2) Mohamed Salah Kamel, Usama Ramadan Abdelmohsen |
| 32 |
[GO] |
2021―Mai―12 |
Computational and experimental insights on the interaction of artemisinin, dihydroartemisinin and chloroquine with SARS-CoV-2 spike protein receptor-binding domain (RBD) |
Giovanni Ribaudo, Paolo Coghi, Li Jun Yang, Jerome P. L. Ng, Andrea Mastinu, Maurizio Memo, et al. (+2) Vincent Kam Wai Wong, Alessandra Gianoncelli |
| 33 |
[GO] |
2021―Mai―06 |
Can nutraceuticals assist treatment and improve covid-19 symptoms? |
Alessio Alesci, Marialuisa Aragona, Nicola Cicero, Eugenia Rita Lauriano |
| 34 |
[GO] |
2021―Mai―06 |
Potential of (Citrus nobilis Lour × Citrus deliciosa Tenora) metabolites on COVID-19 virus main protease supported by in silico analysis |
Seham S. El-Hawary, Marwa Y. Issa, Hanaa S. Ebrahim, Anber F. Mohammed, Alaa M. Hayallah, Essam M. Abd El-Kadder, et al. (+2) Ahmed. M. Sayed, Usama Ramadan Abdelmohsen |
| 35 |
[GO] |
2021―Mai―06 |
Molecular docking of compounds from Clinacanthus nutans extract detected by GC-MS analysis with the SARS-CoV-2 main protease and ACE2 protein |
Noor Zafirah Ismail, Ismail Abiola Adebayo, Nur Nadhirah Mohamad Zain, Hasni Arsad |
| 36 |
[GO] |
2021―Mrz―26 |
Chlorogenic acid, a natural product as potential inhibitor of COVID-19: virtual screening experiment based on network pharmacology and molecular docking |
Wen-Xiang Wang, Ying-Rui Zhang, Shi-Ying Luo, Yun-Sen Zhang, Yi Zhang, Ce Tang |
| 37 |
[GO] |
2020―Okt―30 |
Potential of Ficus microcarpa metabolites against SARS-CoV-2 main protease supported by docking studies |
Heba Ali Hassan, Usama Ramadan Abdelmohsen, Omar M. Aly, Samar Y. Desoukey, Khaled M. Mohamed, Mohamed S. Kamel |
| 38 |
[GO] |
2020―Aug―13 |
Rapid determination and optimisation of berberine from Himalayan Berberis lycium by soxhlet apparatus using CCD-RSM and its quality control as a potential candidate for COVID-19 |
Anil Kumar Katare, Bikarma Singh, Pooja Shukla, Sandeep Gupta, Bishander Singh, Kavya Yalamanchili, et al. (+7) Nitin Kulshrestha, Rajendra Bhanwaria, Ashok Kumar Sharma, Sarita Sharma, Durga Prasad Mindala, Sumit Roy, Rahul Kalgotra |
| 39 |
[GO] |
2020―Jul―09 |
Bioactive compounds from marine resources against novel corona virus (2019-nCoV): in silico study for corona viral drug |
R. Vijayaraj, K. Altaff, A. Sherlin Rosita, S. Ramadevi, J. Revathy |
